Envoy Medical Statistics
Total Valuation
Envoy Medical has a market cap or net worth of $21.91 million. The enterprise value is $46.05 million.
Important Dates
The next estimated earnings date is Thursday, November 13, 2025, after market close.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Envoy Medical has 23.81 million shares outstanding. The number of shares has increased by 21.98% in one year.
| Current Share Class | 23.81M |
| Shares Outstanding | 23.81M |
| Shares Change (YoY) | +21.98% |
| Shares Change (QoQ) | +0.27% |
| Owned by Insiders (%) | 34.20% |
| Owned by Institutions (%) | 56.68% |
| Float | 13.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 83.43 |
| Forward PS | 91.93 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 207.44 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.94
| Current Ratio | 0.94 |
| Quick Ratio | 0.67 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.15 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -148.00% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -1,036.74% |
| Revenue Per Employee | $5,286 |
| Profits Per Employee | -$671,524 |
| Employee Count | 42 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 0.51 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.25% in the last 52 weeks. The beta is 2.07, so Envoy Medical's price volatility has been higher than the market average.
| Beta (5Y) | 2.07 |
| 52-Week Price Change | -62.25% |
| 50-Day Moving Average | 1.17 |
| 200-Day Moving Average | 1.40 |
| Relative Strength Index (RSI) | 46.29 |
| Average Volume (20 Days) | 8,483,604 |
Short Selling Information
The latest short interest is 218,929, so 0.92% of the outstanding shares have been sold short.
| Short Interest | 218,929 |
| Short Previous Month | 178,608 |
| Short % of Shares Out | 0.92% |
| Short % of Float | 1.67% |
| Short Ratio (days to cover) | 0.89 |
Income Statement
In the last 12 months, Envoy Medical had revenue of $222,000 and -$28.20 million in losses. Loss per share was -$1.40.
| Revenue | 222,000 |
| Gross Profit | -582,000 |
| Operating Income | -19.70M |
| Pretax Income | -21.27M |
| Net Income | -28.20M |
| EBITDA | -19.46M |
| EBIT | -19.70M |
| Loss Per Share | -$1.40 |
Full Income StatementBalance Sheet
The company has $5.29 million in cash and $28.83 million in debt, giving a net cash position of -$23.55 million or -$0.99 per share.
| Cash & Cash Equivalents | 5.29M |
| Total Debt | 28.83M |
| Net Cash | -23.55M |
| Net Cash Per Share | -$0.99 |
| Equity (Book Value) | -29.86M |
| Book Value Per Share | -1.39 |
| Working Capital | -487,000 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$15.90 million and capital expenditures -$88,000, giving a free cash flow of -$15.99 million.
| Operating Cash Flow | -15.90M |
| Capital Expenditures | -88,000 |
| Free Cash Flow | -15.99M |
| FCF Per Share | -$0.67 |
Full Cash Flow StatementMargins
| Gross Margin | -262.16% |
| Operating Margin | -8,872.97% |
| Pretax Margin | -9,579.28% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Envoy Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.98% |
| Shareholder Yield | -21.98% |
| Earnings Yield | -125.32% |
| FCF Yield | -71.04% |
Analyst Forecast
The average price target for Envoy Medical is $9.25, which is 905.44% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.25 |
| Price Target Difference | 905.44% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Envoy Medical has an Altman Z-Score of -48.13 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -48.13 |
| Piotroski F-Score | 2 |
